Bill Rastetter

(Dr. William Rastetter Ph.D.)

Currently holds positions in Neurocrine Biosciences Inc, Fate Therapeutics Inc, Regulus Therapeutics Inc and Dare Bioscience Inc

Positions
Position Company Period
Independent Chairman of the Board Neurocrine Biosciences Inc May 1, 2011 -
Independent Chairman of the Board Fate Therapeutics Inc Nov. 1, 2011 -
Independent Director Regulus Therapeutics Inc April 1, 2013 -
Lead Independent Director Dare Bioscience Inc None -
Independent Chairman of the Board Illumina Inc Jan. 27, 2005 - Jan. 28, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-05-03 2023-05-01
PS Planned sale
4,300 -9.1%
101.43
436,135 USD 		4,300 -9.1% 101.43 436,135 USD
2023-04-21 2023-04-21
PS Planned sale
6,034 -13.3%
105.04
633,787 USD 		6,034 -13.3% 105.04 633,787 USD
2023-04-21 2023-04-19
PS Planned sale
903 -2.5%
105.00
94,819 USD 		903 -2.5% 105.00 94,819 USD
2022-04-05 2022-04-01
PS Planned sale
10,728 -24.0%
94.93
1,018,366 USD 		10,728 -24.0% 94.93 1,018,366 USD
2019-05-08 2019-05-07
B Purchase
92,889 +151.4%
1.08
100,320 USD 		92,889 +151.4% 1.08 100,320 USD
2017-07-25 2017-07-25
B Purchase
274,725 +78.5%
0.91
250,000 USD 		274,725 +78.5% 0.91 250,000 USD
2017-03-07 2017-03-07
B Purchase
250,000 +250.0%
1.15
287,500 USD 		250,000 +250.0% 1.15 287,500 USD
2004-05-26 2004-05-24
US Biogen Inc (BIIB)
S Sale
29,081 -26.9%
62.51
1,817,714 USD 		29,081 -26.9% 62.51 1,817,714 USD
2004-05-20 2004-05-19
US Biogen Inc (BIIB)
S Sale
25,000 -18.8%
60.03
1,500,750 USD 		25,000 -18.8% 60.03 1,500,750 USD
2004-05-06 2004-05-04
US Biogen Inc (BIIB)
S Sale
25,000 -13.5%
58.83
1,470,750 USD 		25,000 -13.5% 58.83 1,470,750 USD
2004-05-06 2004-05-04
US Biogen Inc (BIIB)
S Sale
80,000 -47.2%
58.68
4,694,400 USD 		80,000 -47.2% 58.68 4,694,400 USD
2004-05-06 2004-05-04
US Biogen Inc (BIIB)
S Sale
25,000 -12.8%
58.83
1,470,750 USD 		25,000 -12.8% 58.83 1,470,750 USD